Skip to main content
Top
Published in: Intensive Care Medicine 8/2003

01-08-2003 | Neonatal and Pediatric Intensive Care

Admission plasma vasopressin levels in children with meningococcal septic shock

Authors: F. Leclerc, E. Walter-Nicolet, S. Leteurtre, O. Noizet, A. Sadik, R. Cremer, C. Fourier

Published in: Intensive Care Medicine | Issue 8/2003

Login to get access

Abstract

Objective

Vasopressin (AVP) response has been reported to be inappropriately low in adult established septic shock. We studied admission AVP levels in children with meningococcal septic shock (MSS).

Patients and methods

All children with meningococcal infection admitted to our PICU between May 2001 and August 2002 were classified as MSS (persistent hypotension despite fluid therapy, with perfusion abnormalities and the need for vasoactive drug infusion for at least 24 h or until death), or meningococal infection without shock (fever and purpura, with or without meningitis). Blood samples were collected at admission and AVP levels were subsequently determined using Nichols Institute Diagnostics vasopressin assay. Eighteen of 19 children with MSS (7 deaths) and 15 without shock (no death) were included.

Results

In children with MSS median admission AVP level was 41.6 pg/ml (1.4–498.9) and in those without 3.3 pg/ml (1.6–63.8). In children with MSS the AVP level was not correlated with duration of shock and fluid expansion prior to AVP sampling, or with age-adjusted blood pressure and natremia at the time of blood sampling. AVP levels were higher in nonsurvivors, but not significantly so. Only one nonsurvivor had an admission AVP level below 30 pg/ml.

Conclusions

In our children with established MSS who died the admission AVP level Δ were not inappropriately low. Further studies including serial AVP level assessments are needed before concluding that AVP administration is of little interest in children with MSS.
Literature
1.
go back to reference Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588–595PubMed Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588–595PubMed
2.
go back to reference Holmes CL, Patel BM, Russell JA, Walley KR (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–1002PubMed Holmes CL, Patel BM, Russell JA, Walley KR (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–1002PubMed
3.
go back to reference Aiura K, Ueda M, Endo M, Kitajima M (1995) Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit Care Med 23:1898–1906PubMed Aiura K, Ueda M, Endo M, Kitajima M (1995) Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit Care Med 23:1898–1906PubMed
4.
go back to reference Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, Carnio EC (2002) Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 30:1306–1310PubMed Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, Carnio EC (2002) Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 30:1306–1310PubMed
5.
go back to reference Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122–1125PubMed Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122–1125PubMed
6.
go back to reference Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29:487–493PubMed Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29:487–493PubMed
7.
go back to reference Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279–1282PubMed Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279–1282PubMed
8.
go back to reference Malay MB, Ashton RC, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699–705PubMed Malay MB, Ashton RC, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699–705PubMed
9.
go back to reference Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27:1416–1421PubMed Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27:1416–1421PubMed
10.
go back to reference Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93:7–13PubMed Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93:7–13PubMed
11.
go back to reference O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359:1209–1210CrossRefPubMed O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359:1209–1210CrossRefPubMed
12.
go back to reference Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582PubMed Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582PubMed
13.
go back to reference Ryan DW, Kilner AJ (2002) What about vasopressin? Intensive Care Med 28:810–811 Ryan DW, Kilner AJ (2002) What about vasopressin? Intensive Care Med 28:810–811
14.
go back to reference Starc TJ, Rosenzweig EB, Landry DW, Jayakumar A, Smerling AJ, Zucker HA, Trinkaus PM, Biagas KV, Nares MA, Jerome EH, Koumbourlis AC, Schleien CL (2000) Emergency use of vasopressin in children with vasodilatory shock due to sepsis or after bypass. Crit Care Med 28:A71 Starc TJ, Rosenzweig EB, Landry DW, Jayakumar A, Smerling AJ, Zucker HA, Trinkaus PM, Biagas KV, Nares MA, Jerome EH, Koumbourlis AC, Schleien CL (2000) Emergency use of vasopressin in children with vasodilatory shock due to sepsis or after bypass. Crit Care Med 28:A71
15.
go back to reference Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, Landry DW, Galantowicz ME (1999) Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 100 [Suppl II]:II-182–II-186 Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, Landry DW, Galantowicz ME (1999) Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 100 [Suppl II]:II-182–II-186
16.
go back to reference Choi SJ, Jeffries HE, Willis BL, Newth CJ, Bart RD, Wetzel RC (2003) Vaspressin deficiency in pediatric septic shock. Pediatr Crit Care Med 4:141 (A5) Choi SJ, Jeffries HE, Willis BL, Newth CJ, Bart RD, Wetzel RC (2003) Vaspressin deficiency in pediatric septic shock. Pediatr Crit Care Med 4:141 (A5)
17.
go back to reference Martinot A, Leclerc F, Cremer R, Leteurtre S, Fourier C, Hue V (1997) Sepsis in neonates and children: definitions, epidemiology and outcome. Pediatr Emerg Care 13:277–281PubMed Martinot A, Leclerc F, Cremer R, Leteurtre S, Fourier C, Hue V (1997) Sepsis in neonates and children: definitions, epidemiology and outcome. Pediatr Emerg Care 13:277–281PubMed
18.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMed
19.
go back to reference Fourrier F, Bricard H, Cohen Y, Daoud P, Guidet B, Huet F, Laterre PF, Marquette CH, Schaller MD, Sollet JP, Tamion F (2000) Corticothérapie au cours du choc septique et du syndrome de détresse respiratoire aiguë. XXème Conférence de consensus en réanimation et médecine d'urgence. Reanim Urgences 9:597–603 Fourrier F, Bricard H, Cohen Y, Daoud P, Guidet B, Huet F, Laterre PF, Marquette CH, Schaller MD, Sollet JP, Tamion F (2000) Corticothérapie au cours du choc septique et du syndrome de détresse respiratoire aiguë. XXème Conférence de consensus en réanimation et médecine d'urgence. Reanim Urgences 9:597–603
20.
go back to reference Dibley MJ, Staehling N, Nieburg P, Trowbridge FL (1987) Interpretation of z score anthropometric indicators derived from the international growth reference. Am J Clin Nutr 46:749–762PubMed Dibley MJ, Staehling N, Nieburg P, Trowbridge FL (1987) Interpretation of z score anthropometric indicators derived from the international growth reference. Am J Clin Nutr 46:749–762PubMed
21.
go back to reference Task Force on blood pressure control in children (1987) Report of the second Task Force on blood pressure control in children. Pediatrics 79:1–25PubMed Task Force on blood pressure control in children (1987) Report of the second Task Force on blood pressure control in children. Pediatrics 79:1–25PubMed
22.
go back to reference van Doesburg NH, Guimond JG, Mercier JC, Lacroix J, Gauthier M (1994) Surveillance: généralités. In: Lacroix J, Gauthier M, Beaufils F (eds) Urgences et soins intensifs pédiatriques. Les Presses de l'université de Montreal, Doin, Paris, pp 49–78 van Doesburg NH, Guimond JG, Mercier JC, Lacroix J, Gauthier M (1994) Surveillance: généralités. In: Lacroix J, Gauthier M, Beaufils F (eds) Urgences et soins intensifs pédiatriques. Les Presses de l'université de Montreal, Doin, Paris, pp 49–78
23.
go back to reference Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMed Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMed
24.
go back to reference De Groof F, Joosten KFM, Janssen JAMJL, De Kleijn ED, Hazelzet JA, Hop WCJ, Uitterlinden P, Van Doorn J, Hokken-Koelega ACS (2002) Acute stress response in children with meningococcal sepsis: important differences in the growth hormone /insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 87:3118–3124PubMed De Groof F, Joosten KFM, Janssen JAMJL, De Kleijn ED, Hazelzet JA, Hop WCJ, Uitterlinden P, Van Doorn J, Hokken-Koelega ACS (2002) Acute stress response in children with meningococcal sepsis: important differences in the growth hormone /insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 87:3118–3124PubMed
25.
go back to reference Van der Kaay DCM, De Kleijn ED, De Rijke YB, Hop WCJ, De Groot R, Hazelzet JA (2002) Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 28:1606–1612CrossRef Van der Kaay DCM, De Kleijn ED, De Rijke YB, Hop WCJ, De Groot R, Hazelzet JA (2002) Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 28:1606–1612CrossRef
26.
27.
go back to reference Carcillo JA, Fields AI, Task force committee members (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30:1365–1378PubMed Carcillo JA, Fields AI, Task force committee members (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30:1365–1378PubMed
28.
go back to reference Boykin J De Torrente A, Erickson A, Roberston G, Schriver RW (1978) Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency. J Clin Invest 62:738–744PubMed Boykin J De Torrente A, Erickson A, Roberston G, Schriver RW (1978) Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency. J Clin Invest 62:738–744PubMed
29.
go back to reference Papanek PE, Sladek CD, Raff H (1997) Corticosterone inhibition of osmotically stimulated vasopressin from hypothalamic-neurohypophysial explants. Am J Physiol 272:R158–R162PubMed Papanek PE, Sladek CD, Raff H (1997) Corticosterone inhibition of osmotically stimulated vasopressin from hypothalamic-neurohypophysial explants. Am J Physiol 272:R158–R162PubMed
30.
go back to reference Liedel J, Meadow W, Nachman J, Koogler T, Kahana MD (2002) Use of vasopressin in refractory hypotension in children with vadilatory shock: five cases and a review of the literature. Pediatr Crit Care Med 3:15–18PubMed Liedel J, Meadow W, Nachman J, Koogler T, Kahana MD (2002) Use of vasopressin in refractory hypotension in children with vadilatory shock: five cases and a review of the literature. Pediatr Crit Care Med 3:15–18PubMed
31.
go back to reference Scharte M, Meyer J, Van Aken H, Bone HG (2001) Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 29:1756–1760PubMed Scharte M, Meyer J, Van Aken H, Bone HG (2001) Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 29:1756–1760PubMed
32.
go back to reference Kahn JM, Kress JP, Hall JB (2002) Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med 30:1899–1901PubMed Kahn JM, Kress JP, Hall JB (2002) Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med 30:1899–1901PubMed
33.
go back to reference Westphal M, Bone HG, Van Aken H, Sielenkämper AW (2002) Terlipressin for haemodynamic support in septic patients: a double-edged sword? Lancet 360:1250–1251 Westphal M, Bone HG, Van Aken H, Sielenkämper AW (2002) Terlipressin for haemodynamic support in septic patients: a double-edged sword? Lancet 360:1250–1251
34.
go back to reference Asfar P (2003) Terlipressin in chronic hyperdynamic endotoxic shock: is it safe? Intensive Care Med 29:154–155 Asfar P (2003) Terlipressin in chronic hyperdynamic endotoxic shock: is it safe? Intensive Care Med 29:154–155
Metadata
Title
Admission plasma vasopressin levels in children with meningococcal septic shock
Authors
F. Leclerc
E. Walter-Nicolet
S. Leteurtre
O. Noizet
A. Sadik
R. Cremer
C. Fourier
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 8/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1868-y

Other articles of this Issue 8/2003

Intensive Care Medicine 8/2003 Go to the issue